Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Long Infusion Bleomycin in Good Prognosis Germ Cell Tumors (TE3)
NCT00324298Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bleomycin in Testicular Germ Cell Tumor (TGCT), sponsored by Queen Mary University of London. Started Jul 2003; status: completed.
02
Drugs
bleomycin
03
Conditions
Testicular Germ Cell Tumor (TGCT)
Beyond the preview
Go deeper on NCT00324298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324298.